Wouldn't it be great if you could answer these 3 questions everytime?
1) Will a drug be successful?
2) Will a drug make any money?
3) Is it worth investing in a drugs' further development?
In these days of thin pipelines and revenues consolidating into a few products there is high pressure
your company's product managers to be sure that their next product, if not a blockbuster, is at least a winner.
However, you will be fully aware that through Pharmacoeconomics, we can go some way to predict the future success of your drug!
But questions still remain
-- Are Pharmacoeconomics any good?
-- Do Pharmacoeconomics work?
Visiongain's brand new report, answers
these questions for you. This new report examines the link between this new developmental tool, the financial success of drug and how decision makers are increasingly using Pharmacoeconomics to make their drug purchases - are you using Pharmacoeconomics successfully?
Currently there are 4 economic factors in a pharmacoeconomic evaluation:
-- Cost minimisation
-- Cost effectiveness analysis (CEA)
-- Cost benefit analysis (CBA)
-- Cost utility analysis (CUA)
Visiongain's Pharmacoeconomics and Success in the Marketplace
report, examines these steps and points out their usefulness in a drugs' commercial viability and market positioning.
The report also tackles crucial issues such as
:
-- Formulary decisions
-- The
current effective structure of Pharmacoeconomics
-- Data problems in
implementing and succeeding in Pharmacoeconomics
-- The influence of Pharmacoeconomics in the pharmaceutical R&D sector
-- Global Pharmacoeconomic practice from the major industry players
Why You Need
to Order This Report
To fully appreciate how useful Pharmacoeconomics can be
to your company and its decision making process,
you need to
read this
report
today. Packed full of 30 tables and graphs, analytical insight, up to date information,
and all the latest developments, this report is essential in helping
you to come to terms with this new and telling
market developmental tool.
This report is available on a strictly first-come-first-serve basis and only a set number of copies have been produced. I would urge you to contact me as quickly as you can to avoid missing out. I look forward to hearing from you very soon.
This report examines the link between this new developmental tool, the financial success of drug and how decision makers are increasingly using Pharmacoeconomics to make their drug purchases - are you using Pharmacoeconomics successfully?